Načítá se...
Targeting pathogenic Lafora bodies in Lafora disease using an antibody-enzyme fusion
Lafora disease (LD) is a fatal childhood epilepsy caused by recessive mutations in either the EPM2A or EPM2B gene. A hallmark of LD is the intracellular accumulation of insoluble polysaccharide deposits known as Lafora bodies (LBs) in the brain and other tissues. In LD mouse models, genetic reductio...
Uloženo v:
| Vydáno v: | Cell Metab |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6774808/ https://ncbi.nlm.nih.gov/pubmed/31353261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2019.07.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|